Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michel P Hermans

Showing results (11-20 of 122) with videos related to

Pageof 13
Sort By:
Cardiovascular Diabetology|December 16, 2010
log(TG)/HDL-C is related to both residual cardiometabolic risk and β-cell function loss in type 2 diabetes malesMichel P Hermans, Sylvie A Ahn, Michel F Rousseau
Diabetes Care|March 6, 2007
Glucose homeostasis and genotype-phenotype interplay in cystic fibrosis patients with CFTR gene deltaF508 mutationVanessa Preumont, Michel P Hermans, Patrick Lebecque, et al.
Journal of Diabetes|August 15, 2018
Crossing family histories of diabetes and cardiovascular disease leads to unexpected outcomes in diabetic offspringMichel P Hermans, Sylvie A Ahn, Michel F Rousseau
Diabetes & Metabolism|November 10, 2009
Erectile dysfunction, microangiopathy and UKPDS risk in type 2 diabetesMichel P Hermans, Sylvie A Ahn, Michel F Rousseau
BMC Endocrine Disorders|August 7, 2019
Distinction of cardiometabolic profiles among people ≥75 years with type 2 diabetes: a latent profile analysisAntoine Christiaens, Michel P Hermans, Benoit Boland, et al.
Journal of Diabetes and Its Complications|April 24, 2012
The multi-faceted outcomes of conjunct diabetes and cardiovascular familial history in type 2 diabetesMichel P Hermans, Sylvie A Ahn, Michel F Rousseau
Diabetes & Vascular Disease Research|April 7, 2010
Raised natriuretic peptides, big-endothelin-1 and improved beta-cell function in type 2 diabetic males with hyperuricaemiaMichel P Hermans, Sylvie A Ahn, Michel F Rousseau
Cardiovascular Diabetology|March 1, 2013
Discriminant ratio and biometrical equivalence of measured vs. calculated apolipoprotein B100 in patients with T2DMMichel P Hermans, Sylvie A Ahn, Michel F Rousseau
Lipids in Health and Disease|October 11, 2012
The atherogenic dyslipidemia ratio [log(TG)/HDL-C] is associated with residual vascular risk, beta-cell function loss and microangiopathy in type 2 diabetes femalesMichel P Hermans, Sylvie A Ahn, Michel F Rousseau
Diabetes Research and Clinical Practice|February 3, 2024
Novel time-saving OGTT sparing HbA1c-HOMA2 based algorithm for the diagnosis of cystic fibrosis-related diabetesFabian Lurquin, Sophie Gohy, Michel P Hermans, et al.
Pageof 13

Showing results (11-20 of 122) with videos related to

Sort By:
Pageof 13
Cardiovascular Diabetology|December 16, 2010
log(TG)/HDL-C is related to both residual cardiometabolic risk and β-cell function loss in type 2 diabetes malesMichel P Hermans, Sylvie A Ahn, Michel F Rousseau
Diabetes Care|March 6, 2007
Glucose homeostasis and genotype-phenotype interplay in cystic fibrosis patients with CFTR gene deltaF508 mutationVanessa Preumont, Michel P Hermans, Patrick Lebecque, et al.
Journal of Diabetes|August 15, 2018
Crossing family histories of diabetes and cardiovascular disease leads to unexpected outcomes in diabetic offspringMichel P Hermans, Sylvie A Ahn, Michel F Rousseau
Diabetes & Metabolism|November 10, 2009
Erectile dysfunction, microangiopathy and UKPDS risk in type 2 diabetesMichel P Hermans, Sylvie A Ahn, Michel F Rousseau
BMC Endocrine Disorders|August 7, 2019
Distinction of cardiometabolic profiles among people ≥75 years with type 2 diabetes: a latent profile analysisAntoine Christiaens, Michel P Hermans, Benoit Boland, et al.
Journal of Diabetes and Its Complications|April 24, 2012
The multi-faceted outcomes of conjunct diabetes and cardiovascular familial history in type 2 diabetesMichel P Hermans, Sylvie A Ahn, Michel F Rousseau
Diabetes & Vascular Disease Research|April 7, 2010
Raised natriuretic peptides, big-endothelin-1 and improved beta-cell function in type 2 diabetic males with hyperuricaemiaMichel P Hermans, Sylvie A Ahn, Michel F Rousseau
Cardiovascular Diabetology|March 1, 2013
Discriminant ratio and biometrical equivalence of measured vs. calculated apolipoprotein B100 in patients with T2DMMichel P Hermans, Sylvie A Ahn, Michel F Rousseau
Lipids in Health and Disease|October 11, 2012
The atherogenic dyslipidemia ratio [log(TG)/HDL-C] is associated with residual vascular risk, beta-cell function loss and microangiopathy in type 2 diabetes femalesMichel P Hermans, Sylvie A Ahn, Michel F Rousseau
Diabetes Research and Clinical Practice|February 3, 2024
Novel time-saving OGTT sparing HbA1c-HOMA2 based algorithm for the diagnosis of cystic fibrosis-related diabetesFabian Lurquin, Sophie Gohy, Michel P Hermans, et al.
Pageof 13